Filing Details
- Accession Number:
- 0001127602-18-026803
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-05 16:33:30
- Reporting Period:
- 2018-08-31
- Accepted Time:
- 2018-09-05 16:33:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1613103 | Medtronic Plc | MDT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1610035 | Hooman Hakami | 710 Medtronic Pkwy Ms Lc300 Minneapolis MN 55432 | Evp & Group President Diabetes | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2018-08-31 | 399 | $62.76 | 63,046 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2018-08-31 | 7,436 | $62.76 | 70,482 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2018-08-31 | 18,324 | $62.76 | 88,806 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2018-08-31 | 26,159 | $96.29 | 62,647 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2018-08-31 | 399 | $0.00 | 399 | $62.76 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2018-08-31 | 7,436 | $0.00 | 7,436 | $62.76 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2018-08-31 | 18,324 | $0.00 | 18,324 | $62.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-07-28 | No | 4 | M | Direct | |
| 0 | 2024-07-28 | No | 4 | M | Direct | |
| 0 | 2024-07-28 | No | 4 | M | Direct |
Footnotes
- The exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $96.04 to $96.44, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- These options to purchase ordinary shares of New Medtronic for $62.76 per share, which were unvested at the effective time of the Merger, were received in the Merger and represent the conversion of an equal number of Medtronic common stock shares for $62.76 per share. The New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. These options became exercisable in four equal annual installments beginning on July 28, 2015, which was the first anniversary of the grant.
Billionaire Hedge Funds
